Fig 2.

A 30-year-old woman with Zika virus infection with Guillain-Barré syndrome. Postcontrast sagittal T1-weighted image demonstrates enhancement in the cauda equina nerve roots (long arrow) and lumbar spine ganglia bilaterally (short arrows) following injection with a gadolinium-based contrast agent (A). Axial postcontrast, fat-suppressed T1-weighted MR imaging shows gadolinium enhancement of the facial nerves (B, arrows). Axial postcontrast, fat-suppressed T1-weighted MR imaging shows gadolinium enhancement of the trigeminal nerves (C, arrows).